Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery |
Questionnaire Administration, Placebo Administration, Endoxifen Hydrochloride |
Active, not recruiting |
Dexamethasone in Controlling Dyspnea in Patients With Cancer |
Dexamethasone, Questionnaire Administration, Placebo |
Active, not recruiting |
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer |
Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment |
Recruiting |
Treating Pain in Children With Cancer: Pain Buddy |
Pain Buddy |
Recruiting |
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer |
Radiation Therapy, Questionnaire Administration, Quality-of-Life Assessment, Laboratory Biomarker Analysis, Hypofractionated Radiation Therapy |
Active, not recruiting |
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer |
Carvedilol, Laboratory Biomarker Analysis, Patient Observation |
Recruiting |
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma |
Ramipril |
Recruiting |
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment |
Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy |
Palonosetron Hydrochloride, Ondansetron Hydrochloride, Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Placebo |
Active, not recruiting |
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors |
Manual Therapy |
Recruiting |